Incretins and their synthetic mimetics offer benefits by influencing the appetite and satiety centers in the brain, potentially resetting the bodys fat mass and body weight setpoints that are associated with the interplay between orexigenic and anorexigenic signaling pathways
Pinch a fold of skin and fat on your abdomen, thigh, or upper arm, then insert the needle at a 90-degree angle in one smooth motion
Fexofenadine (Allegra): Fexofenadine is known for being very unlikely to cause drowsiness
PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month of treatment) maps 14 metabolic pathways and analyzes 150+ genetic insights related to GLP-1 and tirzepatide response
We highly encourage you follow a balanced, nutritious diet, to get regular exercise, and seek ongoing support from healthcare providers During treatment, our team monitors your progress, adjusts dosages if necessary, and addresses any side effects
Heres what happened: Starting point: Weight: 89.5kg Body fat: 15% Fat mass: 13.4kg Muscle mass: 73.5kg Visceral fat: Level 5 (relatively low) After 3 months: Weight: 77kg Body fat: 8.3% Fat mass: 6.8kg Muscle mass: 71.1kg Visceral fat: Level 2 Total changes: Weight lost: 12.5kg Fat lost: 6.6kg (over a stone of pure fat) Muscle lost: 2.4kg (mostly water, not actual muscle tissue) Visceral fat reduction: 60% Cardiovascular fitness: VO2 max improved from 51 54 (significant increase) Strength: Lost 10-15% on main lifts (bench press, squats, pull-ups)
